Literature DB >> 6861124

Effects of extreme hypoxia on the growth and viability of EMT6/SF mouse tumor cells in vitro.

D C Shrieve, D F Deen, J W Harris.   

Abstract

The purpose of this study was to characterize a model system in which to study hypoxic cell biology in vitro as a function of time under extremely hypoxic conditions. EMT6/SF cells that were maintained at 37 degrees under hypoxic conditions showed no increase in cell number for up to 70 hr. The mitotic index of hypoxic cultures was less than 0.1%, compared to 2.3 to 3.0% in aerated cultures. The plating efficiency of hypoxic cells decreased with time to 20 to 30% of control values by 70 hr. Aerated cultures consumed glucose more rapidly than did hypoxic ones, due to increasing cell number in air. But, on a per cell basis, hypoxic and aerated cells consumed glucose at equal rates (congruent to 1.2 X 10(-4) micrograms/cell/hr). Virtually 100% of the glucose consumed was converted into lactic acid in both aerated and hypoxic cultures. The labeling index and rate of incorporation of [3H]thymidine decreased exponentially with time in hypoxia. However, the percentage of cells with S-phase DNA content remained nearly constant for up to 72 hr. The rate of protein synthesis was suppressed in hypoxic cultures to between 20 and 50% of control (aerated) rates. When cultures were reaerated following 45 hr of hypoxia, congruent to 12 hr was required for resumption of DNA synthesis and cell division. The application of this system to further study of hypoxic cell biology is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861124

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Regulation of proliferation-survival decisions during tumor cell hypoxia.

Authors:  C Schmaltz; P H Hardenbergh; A Wells; D E Fisher
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 2.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells.

Authors:  S D Young; R S Marshall; R P Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin.

Authors:  T Yamauchi; T A Raffin; P Yang; B I Sikic
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Energy metabolism in human melanoma cells under hypoxic and acidic conditions in vitro.

Authors:  R Skøyum; K Eide; K Berg; E K Rofstad
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Changes in growth characteristics and macromolecular synthesis on recovery from severe hypoxia.

Authors:  R E Wilson; P C Keng; R M Sutherland
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

7.  Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells.

Authors:  T Danielsen; M Hvidsten; T Stokke; K Solberg; E K Rofstad
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

8.  Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism.

Authors:  C S Heacock; R M Sutherland
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

9.  Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability.

Authors:  N M Hasan; G E Adams; M C Joiner; J F Marshall; I R Hart
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy)nucleotides.

Authors:  O Amellem; M Löffler; E O Pettersen
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.